General Information |
| Clinical trials phase |
Phases 1/2 |
| Start date (estimated) |
2021-03-01 |
| Clinical feature |
| Label |
dystrophies primarily involving the retinal pigment epithelium |
| Link |
http://purl.obolibrary.org/obo/DOID_14252 |
|
Administrative Information |
| ICTRP weblink |
https://trialsearch.who.int/Trial2.aspx?TrialID=JPRN-jRCTa050200122 |
| Other study identifiers |
| Name |
jRCTa050200122 |
| Description |
Japan Registry of Clinical Trials (jRCT) |
|
| Source weblink |
https://jrct.niph.go.jp/en-latest-detail/jRCTa050200122 |
| Regulatory body approval |
| Name |
The First Certified Special Committee for Regenerative Medicine, Osaka |
| Country |
|
|
| Study sites |
|
| Public contact |
| Email |
e_jrct@kcho.jp |
| Public email |
e_jrct@kcho.jp |
| First name |
Shigeki |
| Last name |
Yamasaki |
| Phone |
+81-78-381-9876 |
| City |
Kobe |
| Country |
|
| Address freetext |
2-1-8 Minatojima-minamimachi, Chuo-ku, Kobe Hyogo, Japan |
|
Cells |
| Which differentiated cell type is used |
| Label |
retinal pigment epithelial cell |
| Link |
http://purl.obolibrary.org/obo/CL_0002586 |
| Description |
An epithelial cell of the retinal pigmented epithelium. |
|
Recruitment |
| Recruitment Status |
Unknown Status |
| Comment recruitment status |
Not Recruiting |
| Estimated number of participants |
50 |
